NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 298 filers reported holding NEOGENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,269 | -9.7% | 2,217 | +18.0% | 0.00% | 0.0% |
| Q2 2023 | $30,196 | -28.3% | 1,879 | -21.5% | 0.00% | -42.9% |
| Q1 2023 | $42,141 | -84.2% | 2,393 | -91.7% | 0.01% | -86.5% |
| Q4 2022 | $267,073 | +44.4% | 28,904 | +34.7% | 0.05% | +33.3% |
| Q3 2022 | $185,000 | +1.1% | 21,454 | -4.2% | 0.04% | 0.0% |
| Q2 2022 | $183,000 | -35.6% | 22,405 | +2.2% | 0.04% | -25.0% |
| Q1 2022 | $284,000 | -30.7% | 21,919 | +20.0% | 0.05% | -22.4% |
| Q4 2021 | $410,000 | -41.0% | 18,270 | +14.0% | 0.07% | -46.4% |
| Q3 2021 | $695,000 | 0.0% | 16,029 | 0.0% | 0.12% | 0.0% |
| Q2 2021 | $695,000 | -4.7% | 16,029 | +6.1% | 0.12% | -13.2% |
| Q1 2021 | $729,000 | -5.7% | 15,111 | +5.3% | 0.14% | -10.0% |
| Q4 2020 | $773,000 | +48.9% | 14,355 | +9.3% | 0.16% | +11.1% |
| Q3 2020 | $519,000 | -68.2% | 13,128 | -75.9% | 0.14% | +105.7% |
| Q1 2020 | $1,634,000 | – | 54,472 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |